Home Drug Codes J Codes J0740 · CIDOFOVIR
Updated July 1st, 2026

CIDOFOVIR J Code: J0740

Injection, cidofovir, 375 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J0740, effective October 1, 2026: $522.238 per HCPCS billing unit, down 2.5% from $535.735. From CMS's final file.

?
Medicare Payment Limit ?
$535.735
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
$535.735
/ HCPCS billing unit · APC 9033
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
2
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, cidofovir, 375 mg
HCPCS Added Date January 1, 1998
Manufacturer Multiple Manufacturers
Route of Administration Intravenous
Generic Status Multi-Source; Generic
Dosage Type Single-Dose
Dosage Form Injection, Solution

About CIDOFOVIR

Cidofovir is a medication aligned to the HCPCS J Code: J0740 for billing, pricing, and reimbursement purposes in the United States. Classified under Antiviral, it is administered via the intravenous route and manufactured by multiple companies.

According to CMS Drug Use Information: This drug is used with probenecid to treat a certain viral eye infection (retinitis due to cytomegalovirus-CMV) in people with AIDS. It lowers your risk of blindness and other vision problems. Cidofovir belongs to a class of drugs known as antivirals. It works by stopping the growth of the virus. Cidofovir is not a cure for CMV retinitis, and your disease may still worsen during and after treatment.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
23155-0216-31 Cidofovir Dihydrate Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 1 375 MG / 5 ML
67457-0210-05 Cidofovir Mylan Institutional LLC 1 375 MG / 5 ML
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

CIDOFOVIR Pricing & Reimbursement

J0740 Private Payer Reimbursement
$529.81 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

CIDOFOVIR CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
JW / JZ modifiers apply

CMS has identified Cidofovir (J0740) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

CIDOFOVIR Medically Unlikely Edits (MUE)

The most billing units of J0740 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 375 mg.

Practitioner Office & Hospital Outpatient
2 units / day
= 750 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

CIDOFOVIR Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

CMV retinitis
Drug Class
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]DNA Polymerase Inhibitors [MoA]Nucleoside Analog [EXT]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Cidofovir billing and coding guide?
We have not yet identified a manufacturer source of Cidofovir billing and coding information.
Are there any available Cidofovir patient assistance programs?
Our team did not identify a source for Cidofovir patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Cidofovir prescribing information?
Our team is still working to identify a prescribing information source for CIDOFOVIR
Where can I find Cidofovir side effect information?
Our team has not yet identified a source of side effects information for CIDOFOVIR. Please check back in a few weeks.
Does billing CIDOFOVIR require JZ/JW wastage modifiers?
CMS has identified CIDOFOVIR(J0740) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.